2001
DOI: 10.1159/000055812
|View full text |Cite
|
Sign up to set email alerts
|

Infections in Pancreatic Inflammatory Disease: Clinical Trials for Antibiotic Prophylaxis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
1
0
1

Year Published

2002
2002
2019
2019

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 9 publications
(2 citation statements)
references
References 12 publications
0
1
0
1
Order By: Relevance
“…Finally, the antibiotics used in the studies varied ( table 3 ); one study with imipenem [14] , one study with meropenem [19] , two with cephalosporins [13,15] , and two with a combination of third-generation fluoroquinolones and metronidazole [7,16] . This makes it difficult to compare the outcome, since it could be influenced by, amongst others, the level of penetration of the antibiotics in (necrotic) pancreatic tissue and the antimicrobial spectrum of the antibiotics [27][28][29][30] .…”
Section: Discussionmentioning
confidence: 99%
“…Finally, the antibiotics used in the studies varied ( table 3 ); one study with imipenem [14] , one study with meropenem [19] , two with cephalosporins [13,15] , and two with a combination of third-generation fluoroquinolones and metronidazole [7,16] . This makes it difficult to compare the outcome, since it could be influenced by, amongst others, the level of penetration of the antibiotics in (necrotic) pancreatic tissue and the antimicrobial spectrum of the antibiotics [27][28][29][30] .…”
Section: Discussionmentioning
confidence: 99%
“…22,26,27,28,31,32 São muitos os fatores responsáveis pelo prognóstico desfavorável na PA grave, dentre eles se destacam a ocorrência de complicações decorrentes da síndrome da resposta inflamatória sistêmica (SRIS) e a ocorrência de infecção pancreática. 5,6,8,23,27,28,31,33,34,35 Duas fases são determinantes na evolução e no prognóstico da PA Este fato suporta a teoria de participação dos macrófagos na translocação bacteriana em inflamações sistêmicas graves.…”
Section: -Introduçãounclassified